IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $293,673 | +61.7% | 7,465 | 0.0% | 0.01% | +55.6% |
Q1 2023 | $181,623 | +1.9% | 7,465 | -10.3% | 0.01% | +12.5% |
Q4 2022 | $178,217 | +32.1% | 8,324 | +10.7% | 0.01% | +14.3% |
Q3 2022 | $134,891 | +86.5% | 7,519 | 0.0% | 0.01% | +133.3% |
Q2 2022 | $72,333 | -42.8% | 7,519 | 0.0% | 0.00% | -40.0% |
Q1 2022 | $126,545 | -74.6% | 7,519 | -74.8% | 0.01% | -28.6% |
Q4 2021 | $499,059 | +12.8% | 29,848 | +9.6% | 0.01% | +16.7% |
Q3 2021 | $442,475 | +177.1% | 27,246 | +7.7% | 0.01% | +200.0% |
Q2 2021 | $159,693 | +106.8% | 25,308 | +102.5% | 0.00% | +100.0% |
Q1 2021 | $77,219 | -50.3% | 12,495 | -44.5% | 0.00% | -50.0% |
Q4 2020 | $155,523 | +9.2% | 22,507 | -10.8% | 0.00% | 0.0% |
Q3 2020 | $142,376 | +78.1% | 25,244 | +61.0% | 0.00% | +100.0% |
Q2 2020 | $79,953 | – | 15,677 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |